References
  1. Elder JT, Nair RP, Guo Sun-Wei, Henseler T, Christophers E, Voorhees JJ. The genetics of psoriasis. Archives of Dermatological Research. 1994;130(2):216-24.
  2. Watson W, Cann HM, Farber EM, Nall ML. The genetics of psoriasis. Archives of Dermatological Research. 1972;105(2):197-207.
  3. Abu-Elmagd K, Van Thiel D, Jegasothy BV, Acherman CD, Todo S, Fung JJ, Thomson AW, Starzl TE. FK506: A new therapeutic agent for severe recalcitrant psoriasis. Transplantation Proceedings. 1991;23(6):3322-4.
  4. Gottlieb SL, Gilleaudeau P, Johnson R, Estes L, Woodworth TG, Gottlieb AB, Krueger JG. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Medicine. 1995;1(5):442-7.
  5. Hancock GE, Kaplan G, Cohn ZA, Keratinocyte growth regulation by the products of immune cells. Journal of Experimental Medicine. 1988;168(4):1395-402.
  6. Bhalerao J, Bowcock AM. The genetics of psoriasis: A complex disorder of the skin and immune system. Human Molecular Genetics. 1998;7(10):1537-45.
  7. Ayala F. Clinical presentation of psoriasis. Reumatismo. 2007;59(1):40-5.
  8. Hochberg MC, Boyd RE, Ahearn JM, Arnett FC, Bias WB, Provost TT, Stevens MB. Systemic lupus erythematosus: a review of clinic-laboratory features and immunogenetic markers in 150 patients with emphasis on dermographic subsets. Medicine. 1985;64(5):285-95.
  9. Bangert JL, Freeman RG, Sontheimer RD, Gilliam JN. Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings. Archives of Dermatological Research. 1984;120(3):332-7.
  10. Luis Requena, Celia Requena and Clay J. Cockerell.Benign epidermal Tumors and prolifrations In:Bolognia JL, Jorizzo JL, Schaffer JV, eds. Dermatology, 4th edn.New York City, NY: ELSEVIER; 2018:1911-1912.
  11. Peter C. M. van de Kerkhof and Frank O. Nestlé.Psoriasis In:Bolognia JL, Jorizzo JL, Schaffer JV, eds. Dermatology, 4th edn.New York City, NY: ELSEVIER; 2018:150- 151.
  12. Hofer T. Does Inflammatory Linear Verrucous Epidermal Nevus Represent a Segmental Type 1/Type 2 Mosaic of Psoriasis? Dermatology. 2006;212(2):103–7.
  13. Lee SH, Rogers M. Inflammatory linear verrucous epidermal naevi: a review of 23 cases. Australasian Journal of Dermatology. 2001;42(4):252–6.
  14. Tiilikainen A, Lassus A, Karvonen J, Vartianen P, Julin M. Psoriasis and HLA-Cw6. Journal of Dermatology. 1980;102(2):179–84.
  15. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. Journal of the American Academy of Dermatology. 1985;13(3):450-6.
  16. Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stastny P, Menter A, Bowcock A. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science. 1994;264(5162):1141-5.
  17. Lowes MA, Chamian F, Abello MV, Fuentes-Duculan J, Lin SL, Nussbaum R, Novitskaya I, Carbonaro H, Cardinale I, Kikuchi T, Gilleaudeau P, Sullivan-Whalen M, Wittkowski KM, Papp K, Garovoy M, Dummer W, Steinman RM, Krueger JG. Increase in TNF- α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proceedings of the National Academy of Sciences of the United States of America. 2005;102(52):19057–62.
  18. Arican O, Aral M, Sasmaz S, Ciragil P. Serum level of TNF-α,IFN-γ,IL-6,IL-8,IL-12,IL-17,and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators of Inflammation. 2005;2005(5):273-9.
  19. Schottelius AJG, Moldawer LL, Dinarello CA, Asadullah K, Sterry W, Edwards 3rd CK. Biology of tumor necrosis factor-alpha -implications for psoriasis. Experimental Dermatology. 2004;13(4):193-222.
  20. Victor FC,Gottlieb AB, Menter M. Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-α) blockade in psoriasis and psoriatic arthritis. Clinical Dermatology. 2003;21(5):392-7.
  21. Happle R. Segmental Typ-2 Manifestation autosomal dominant skin disease. Development of a new formal genetic concept. Hautarzt. 2001;52(4):283-7.
  22. Poblete-Gutierrez P, Wiederholt T, König A,Jugert FK, Marquardt Y, Rubben A, Merk HF,Happle R, Frank J. Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. Journal of Clinical Investigation. 2004;114(10):1467-74.
  23. Happle R. Loss of heterozygosity in human skin. Journal of the American Academy of Dermatology. 1999;41(2 Pt 1):143-64.